RNA sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profiles

Details for Australian Patent Application No. 2008288241 (hide)

Owner Coley Pharmaceutical GmbH

Inventors Jurk, Marion; Vollmer, Jorg Heinz

Agent Spruson & Ferguson

Pub. Number AU-B-2008288241

PCT Pub. Number WO2009/022216

Priority 60/964,448 13.08.07 US

Filing date 8 August 2008

Wipo publication date 19 February 2009

Acceptance publication date 1 December 2011

International Classifications

A61K 31/7105 (2006.01) - Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links

A61K 39/39 (2006.01) Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 37/04 (2006.01) Drugs for immunological or allergic disorders

C12N 15/117 (2010.01) Mutation or genetic engineering - Nucleic acids having immunomodulatory properties, e.g. containing CpG-motifs

Event Publications

11 March 2010 PCT application entered the National Phase

  PCT publication WO2009/022216 Priority application(s): WO2009/022216

1 December 2011 Application Accepted

  Published as AU-B-2008288241

29 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008288256-A 3' -based sequencing approach for microarray manufacture

2008288225-Articular cartilage, device and method for repairing cartilage defects